Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040673
Filing Date
2019-11-06
Accepted
2019-11-06 07:31:30
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q achv-10q_20190930.htm 10-Q 2015521
2 EX-31.1 achv-ex311_7.htm EX-31.1 9051
3 EX-31.2 achv-ex312_9.htm EX-31.2 9087
4 EX-32.1 achv-ex321_6.htm EX-32.1 4847
5 EX-32.2 achv-ex322_8.htm EX-32.2 4872
  Complete submission text file 0001564590-19-040673.txt   6583269

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT achv-20190930.xml EX-101.INS 1280670
7 XBRL TAXONOMY EXTENSION SCHEMA achv-20190930.xsd EX-101.SCH 50713
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20190930_cal.xml EX-101.CAL 44414
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20190930_def.xml EX-101.DEF 180444
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20190930_lab.xml EX-101.LAB 403349
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20190930_pre.xml EX-101.PRE 310392
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 191195076
SIC: 2835 In Vitro & In Vivo Diagnostic Substances